- Home
- ATXG vs CNSP Comparison
ATXG vs CNSP Comparison
Compare ATXG & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- CNSP
- Stock Information
- Founded
- ATXG 2014
- CNSP 2017
- Country
- ATXG China
- CNSP United States
- Employees
- ATXG N/A
- CNSP N/A
- Industry
- ATXG Professional Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- CNSP Health Care
- Exchange
- ATXG Nasdaq
- CNSP Nasdaq
- Market Cap
- ATXG 3.8M
- CNSP 4.0M
- IPO Year
- ATXG N/A
- CNSP 2019
- Fundamental
- Price
- ATXG $1.01
- CNSP $10.26
- Analyst Decision
- ATXG
- CNSP Strong Buy
- Analyst Count
- ATXG 0
- CNSP 1
- Target Price
- ATXG N/A
- CNSP $20.00
- AVG Volume (30 Days)
- ATXG 1.1M
- CNSP 50.6K
- Earning Date
- ATXG 11-13-2025
- CNSP 11-14-2025
- Dividend Yield
- ATXG N/A
- CNSP N/A
- EPS Growth
- ATXG N/A
- CNSP N/A
- EPS
- ATXG N/A
- CNSP N/A
- Revenue
- ATXG $4,310,835.00
- CNSP N/A
- Revenue This Year
- ATXG N/A
- CNSP N/A
- Revenue Next Year
- ATXG N/A
- CNSP N/A
- P/E Ratio
- ATXG N/A
- CNSP N/A
- Revenue Growth
- ATXG N/A
- CNSP N/A
- 52 Week Low
- ATXG $0.36
- CNSP $4.93
- 52 Week High
- ATXG $1.86
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- ATXG 63.44
- CNSP 69.30
- Support Level
- ATXG $0.82
- CNSP $8.50
- Resistance Level
- ATXG $1.17
- CNSP $9.24
- Average True Range (ATR)
- ATXG 0.16
- CNSP 0.49
- MACD
- ATXG 0.00
- CNSP 0.01
- Stochastic Oscillator
- ATXG 56.90
- CNSP 94.44
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.